John Maraganore, Chief Executive Officer at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 74,000 shares at $125.54 ($9.4M) on 2017-11-15, disclosed to the SEC on 2017-11-17.
Open-market sale of $9.4M ALNY by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $125.54 | 22,460 | $2.8M | 30.0% |
| 2 | $126.60 | 28,399 | $3.6M | 38.3% |
| 3 | $127.54 | 7,120 | $908K | 9.7% |
| 4 | $128.48 | 10,571 | $1.4M | 14.5% |
| 5 | $129.57 | 4,850 | $628K | 6.7% |
| 6 | $130.22 | 600 |
| $78K |
| 0.8% |
| Total | $126.86 avg | 74,000 | $9.4M | 100% |
| Filing → |
| ALNY | SELL | 2021-05-17 | $8.9M | — | Filing → |
| ALNY | SELL | 2021-02-26 | $9.4M | — | Filing → |
| ALNY | SELL | 2020-11-20 | $8.6M | — | Filing → |